AtaCor Medical Inc. closes $28M in Series C financing led by Arboretum Ventures to deliver next generation extravascular ICD and pacing options for cardiac rhythm management
Amount Raised
$28 Million
Round Type
Series C
San ClementeBiotechnologyHealth CareMedicalMedical DeviceInvestors
Description
AtaCor Medical Inc. has completed a $28M Series C financing round led by Arboretum Ventures and including existing investors Longview Ventures, Hatteras Venture Partners, Catalyst Health Ventures, and BayMed Venture Partners. The funding supports FDA submission for its extravascular temporary pacing lead system and completion of a pilot study for the third generation EV-ICD lead system. AtaCor plans to use the new funds to support these regulatory submissions and clinical milestones for their proprietary extravascular pacing & implantable cardioverter defibrillator lead systems.
Quick answer
AtaCor Medical raised $28 Million in a Series C round, dated April 24, 2024. Investors: Bay Med Venture Partners, Catalyst Health Ventures, Hatteras Venture Partners, Longview Ventures and Arboretum Ventures. AtaCor Medical is based in San Clemente, California, United States.
- How much did AtaCor Medical raise?
- AtaCor Medical raised $28 Million in a Series C round on April 24, 2024.
- Who invested in AtaCor Medical?
- Bay Med Venture Partners, Catalyst Health Ventures, Hatteras Venture Partners, Longview Ventures and Arboretum Ventures are named as investors in this round.
- What does AtaCor Medical do?
- Atacor Medical is transforming cardiac pacing and defibrillation lead technology with its proprietary extravascular cardiac rhythm management system that provides the full benefits of traditional, transvenous..
- Where is AtaCor Medical based and how big is it?
- AtaCor Medical is based in San Clemente, California, United States.
- Who are the decision-makers at AtaCor Medical?
- Fundz holds 1 contact at AtaCor Medical. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Medical Device around the same time
Companies in the same sectors as AtaCor Medical that raised within 45 days of this round, from Fundz verified event records.
- Novocuff raised $6.8M on June 4, 2024.
- May Health raised $25M (Series B) on May 13, 2024.
- Nami Surgical raised $4M (Seed) on May 8, 2024.
- Inheart raised $11M (Funding Round) on May 7, 2024.
- neuroClues raised $5.4M (Pre-Series A) on April 30, 2024.
- Flyte raised $5M (Seed) on April 22, 2024.
Who to call at AtaCor Medical, and when
A new round usually means AtaCor Medical is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day AtaCor Medical raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at AtaCor Medical, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at AtaCor Medical. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment AtaCor Medical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
AtaCor Medical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.